Skip to Content
Digital Diagnostics' flagship product has been renamed LumineticsCore™ Read More
string(8) "Insights"
Autonomous AI Prevents Blindness by Increasing Eye Exam for Diabetes Access for So-Cal Patients: White Paper
Eye Anatomy: The Structures of the Eye and Their Functions
OSF Healthcare’s Journey with LumineticsCore
Eye-Opening AI Changes the Way Patients are Diagnosed
LumineticsCore: A letter from the CEO
Corridor Business Journal Tells Digital Diagnostics’ Story Through the Years
Leading with Speed and Grace – An Interview with Seth Rainford
High Quality Home Studio Setup with Michael Abramoff
Digital Diagnostics hosted the Congressional Healthy Futures Task Force, Modernization Subcommittee
8 Questions to Ask When Evaluating an Autonomous AI System that Detects Diabetic Retinopathy
Do People with Diabetes Avoid Diabetic Eye Exams?
What is Diabetic Retinopathy: How Primary Care Can Protect Patients with Diabetes
Digital Diagnostics Celebrates CMS’s Historic Decision to Finalize a National Rate for CPT 92229
In the Trenches of AI Commercialization
CMS Releases Proposed Changes to CY ’22 Medicare Physician Fee Schedule
Reducing Preventable Blindness is a Global Reality with an Orbis and Digital Diagnostics Partnership
Pre-2012 startups and AI products across medical specialties
3Derm is acquired!
How to Choose the Reference Standard for an AI Clinical Trial
Treating Diabetic Retinopathy
What your patients can expect during a diabetic retinopathy exam
The AMA paves the way for AI innovation with new policy recommendations
The biggest hurdle to creating an AI for glaucoma detection
How to Successfully Complete Comprehensive Diabetes Care Documentation
